(Q45222007)

English

Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls

scientific article published in March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls (English)

1 reference

Europe PubMed Central

11 December 2017

0 references

6

object named as

Donald Hedeker

1 reference

Europe PubMed Central

11 December 2017

author name string

Brian Hitsman

1

1 reference

Europe PubMed Central

11 December 2017

Bonnie Spring

2

1 reference

Europe PubMed Central

11 December 2017

William Wolf

3

1 reference

Europe PubMed Central

11 December 2017

Regina Pingitore

4

1 reference

Europe PubMed Central

11 December 2017

John W Crayton

5

1 reference

Europe PubMed Central

11 December 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

11 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

11 December 2017

30

1 reference

Europe PubMed Central

11 December 2017

3

1 reference

Europe PubMed Central

11 December 2017

640-648

1 reference

Europe PubMed Central

11 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300651

0 references

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

The role of serotonin in craving: from basic research to human studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

A randomized trial of sertraline as a cessation aid for smokers with a history of major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Naltrexone increases the latency to drink alcohol in social drinkers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Schizophrenia and smoking: an epidemiological survey in a state hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Acute tryptophan depletion in schizophrenic patients treated with clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Acute tryptophan depletion in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Signs and symptoms of tobacco withdrawal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Prevalence of smoking among psychiatric outpatients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Nicotine patch and paroxetine for smoking cessation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Drug addiction, dysregulation of reward, and allostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Serotonergic basis of antipsychotic drug effects in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Differences between males and females in rates of serotonin synthesis in human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Addictive behaviors among hospitalized psychiatric patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Double-blind trial of the effects of tryptophan depletion on depression and cerebral blood flow in smokers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Effects of tryptophan depletion on acute smoking abstinence symptoms and the acute smoking response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

21 January 2018

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotine and caffeine use as confounds in psychiatric studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

7 January 2021

based on heuristic

inferred from DOI database lookup

The concept of craving and its measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight gain and withdrawal symptoms after smoking cessation: a preventive intervention using d-fenfluramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300651

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300651

1 reference

Europe PubMed Central

11 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45222007&oldid=2070461322"